Quantum Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Sell
3,371
-95
-3% -$12.5K 0.04% 139
2026
Q1
$483K Buy
3,466
+108
+3% +$15.1K 0.05% 109
2025
Q4
$412K Buy
3,358
+7
+0.2% +$851 0.05% 132
2025
Q3
$372K Buy
3,351
+2
+0.1% +$227 0.05% 122
2025
Q2
$371K Buy
3,349
+91
+3% +$9.69K 0.05% 114
2025
Q1
$365K Buy
3,258
+730
+29% +$75.3K 0.05% 103
2024
Q4
$234K Hold
2,528
0.04% 161
2024
Q3
$212K Buy
+2,528
New +$193K 0.03% 173

Other funds holding GILD

Quantum Financial Advisors's GILD Position: Q2 2026 in Review

Quantum Financial Advisors reduced its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, selling an estimated $12.5K and leaving 3,371 shares worth $426K. The position accounts for 0.04% of the portfolio, ranked #139.

Quantum Financial Advisors first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $483K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quantum Financial Advisors held 3,371 shares of Gilead Sciences worth $426K as of Q2 2026.
  • Quantum Financial Advisors sold 95 Gilead Sciences shares in Q2 2026, an estimated $12.5K.
  • Gilead Sciences made up 0.04% of Quantum Financial Advisors's portfolio in Q2 2026, its #139 holding.
  • Quantum Financial Advisors first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • Quantum Financial Advisors's Gilead Sciences position peaked at $483K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quantum Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.